FAFernanda Viana de Almeida

Fernanda Viana de Almeida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fernanda Viana de Almeida has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Segurança e eficácia do dimesilato de lisdexanfetamina em transtorno de déficit de atenção e hiperatividade: uma revisão literária

    by Fernanda Duarte Maciel, Maria Eduarda Fonseca, Jéssyka Viana Valadares Franco, João Paulo Silva Azeredo, Allan Michael de Lima, Fernanda Viana de Almeida, Fernanda Paim Braga da Silva, Késia Castro de Aguiar, Gustavo Soares Lobo, João Paulo de Jesus Soares Leal

    Attention Deficit Hyperactivity Disorder (ADHD) is a neurological disorder that is associated with poor brain performance. Individuals with ADHD have dyslexia, a certain impulsiveness and difficulty concentrating, resulting in poor school development. Taking into account, about 2.5 million new cases are declared per year in Brazil, whether due to real necessity or mere mediocrity of the diagnosis. Lisdexamfetamine methylphenidate is the main representative of a new class of long-acting agents for the treatment of ADHD, in current scenarios it has been the drug traditionally used as first choice for the treatment of children and adolescents with ADHD. Therefore, the general objective of this study was to analyze the effects that lisdexamfetamine dimesylate has for individuals with ADHD. In the methodology, a literature review was carried out, including studies in Portuguese and published between 2017 and 2022. Data collection took place in PubMed, LILACS, Scielo and Google Scholar databases. In the results, the safety and efficacy of lisdexamfetamine dimesylate for patients with ADHD proved to be effective and positive. In the studies found, it was understood that this drug has as its mechanism of action the blockade of the reuptake of the neurotransmitter dopamine and the stimulus to its production and noradrenaline. This action is what makes the stimulant of this medicine effective.